en

PRODUCT DETAIL

Rybelsus 14 mg tablety

Code 4671D
MA number EU/1/20/1430/008
Product Form: tbl 30x14 mg (blis.Al/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BJ Glucagon-like peptide-1 receptor (GLP-1) analogues
A10BJ06 Semaglutide
Shelf life: 30
Container: blister Al/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 03.04.2020
Validity: 03.04.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 29.05.2020
eu-flag.png sk-flag.png